Increased Development of Targeted Therapies in the Neuroendocrine Tumors Pipeline Promises a Shift in the Standard of Care

Kognitic Clinical Trial Intelligence (CTI) is an automated and robust, insight-driven platform for life sciences, which accelerates our clients' drug development pipeline and investment decisions.

Pilloxa creates digital and remote solutions to optimise clinical trials and patient support programmes through supporting medical adherence and patient retention.

Emisphere Technologies designs unique intracellular drug delivery mechanisms and advanced oral formulations for pharmaceutical developers.